Home / Jamjoom Pharmaceuticals Factory Co. / 2021 Annual Results

Jamjoom Pharmaceuticals Factory Co. 2021 Annual Results

Revenue

SAR 261M

Net Profit

SAR 171M

Jamjoom Pharmaceuticals Factory Co. (4015) reported full year 2021 revenue of SAR 261M, down 10.6% from SAR 292M in 2020. Net profit came in at SAR 171M, down 17.5% year on year. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Key Financial Metrics

Metric	2021	2020
Revenue	SAR 261M	SAR 292M
Net Profit	SAR 171M	SAR 207M
Gross Profit	SAR 475M	SAR 513M
Net Margin	65.4%	70.8%
ROE	13.9%	17.5%
Total Assets	SAR 1.43B	SAR 1.50B
Total Equity	SAR 1.23B	SAR 1.18B

Year on Year Comparison

Revenue decreased by 10.6% compared to 2020. Net profit decreased by 17.5%. Both revenue and profit declined year on year.

View full company profile →

View all years:

2025 2024 2023 2022 2021 2020 2019

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2023-06-21.